Market Tracker

09/04 6:45pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

38.36
Delayed Data
As of Sep 04
 +0.36 / +0.95%
Today’s Change
30.30
Today|||52-Week Range
39.95
+12.62%
Year-to-Date

Today’s Trading

Previous close38.00
Today’s open37.53
Day’s range37.36 - 39.00
Volume415,995
Average volume (3 months)790,216
Market cap$2.6B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-52.00%
Earnings growth (this year)+13.42%
Earnings growth (next 5 years)+7.58%
Revenue growth (last year)-7.08%
P/E ratio35.6
Price/Sales3.50
Price/Book3.95

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co+0.30+0.75%
CXRXConcordia Healthcare...+1.78+2.16%
CBPOChina Biologic Produ...+0.24+0.25%
INSYINSYS Therapeutics I...+0.65+1.94%
Data as of 4:14pm ET, 09/04/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.35
Annual revenue (last year)$723.1M
Annual profit (last year)$80.2M
Net profit margin11.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts